CLSA Capital Partners (CLSA CP) has co-led a funding round of undisclosed size for ACT Genomics, a Taiwan-based developer of genetic sequencing and diagnostic services.
The transaction represents the first investment from Aria V, CLSA CP’s latest growth capital fund, which launched earlier this year and targets companies positioned to benefit from changing Asian demographics....
Most traditional large-cap buyout funds have become hybrids in Asia, taking minority stakes in businesses to generate deal flow in certain markets and to harness regional growth trends
Addor Capital – a Chinese VC firm backed by Jiangsu High-Tech Investment Group, also known as Govtor Capital – has raised RMB1.56 billion ($241 million) for its second renminbi-denominated healthcare fund.
India’s Trifecta Capital has closed its second venture debt fund with $140 million in commitments. The firm raised about $68.4 million for its debut vehicle in 2017.
Gitai, a Japanese start-up developing a humanoid general-purpose work robot for use in space, has secured a JPY1.8 billion ($17 million) Series B round from local VCs.